Course Description
Specimens represented by prostate needle core biopsies, transurethral resection of prostate (TURP), radical prostatectomy, kidney biopsies, nephrectomy (radical or partial), bladder biopsies, cystectomy (radical or partial), cystoprostatectomy, testicular biopsies or orchiectomy are frequently handled by pathology residents/fellows, general surgical pathologists and/or urologic pathologists in academic institutions and private practices. These specimens are associated with potential diagnostic challenges and risks in day-to-day practice. This experienced faculty has selected exemplary cases from their expert consultation files (and routine in-house cases) that illustrate recurrent professional practice gaps in urologic pathology. Through intimate mentoring, you will learn how to approach them, make accurate diagnoses, and avoid traps and pitfalls that could cause diagnostic error. The course is pragmatic, clinically-oriented and stimulating.
Target Audience
Practicing academic and community pathologists, and pathologists-in-training
Learning Objectives
Upon completion of this educational activity, learners will be able to:
- Recognize the most common benign mimickers of prostate cancer, identify therapy-related changes in the prostate and be aware of traps and pitfalls
- Identify secondary tumors involving the prostate, tumors arising from the prostatic urethra, and histologic variants of prostate cancer
- Update pathologists on newly-described entities in renal neoplasia, including guidelines for using immunohistochemistry in the work-up of renal tumors
- Develop a systematic approach to the diagnosis of bladder lesions, primary and secondary bladder tumors, benign mimickers of malignancy and staging criteria
- Introduce the new concepts and entities presented in the WHO 2016 Classification of Testicular Tumors including differential diagnoses, morphologic mimics and prognostic significance
Continuing Medical Education and Continuing Certification
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 12 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) and Lifelong Learning (Part II) credit for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit. Physicians can earn a maximum of 12 SAM/Part II credit hours.
Disclosures
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty and coordinators reported no relevant financial relationships: Adeboye O. Osunkoya, MD, L. Priya Kunju, MD, Steven S. Shen, MD, PhD, Kiril Trpkov, MD
USCAP staff associated with the development of content for this activity reported no relevant financial relationships.
Topics/Speaker:
Traps and Pitfalls to Avoid in Kidney Pathology
Traps and Pitfalls to Avoid in Prostate Pathology
Traps and Pitfalls to Avoid in Testicular Pathology
Access to this course expires on: September 24, 2022
